Publication Search Results
Exact matches for:
- Author = Long GV
1.
Mao Y, Gide TN, Adegoke NA, Quek C, Maher N, Potter A, Patrick E, Saw RM, Thompson JF, Spillane AJ, Shannon KF, Carlino MS, Lo SN, Menzies AM, da Silva IP, Long GV, Scolyer RA, Wilmott JS
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, Camelia Quek, Nigel Maher, Alison Potter, Ellis Patrick, Robyn M Saw, John F Thompson, Andrew J Spillane, Kerwin F Shannon, Matteo S Carlino, Serigne N Lo, Alexander M Menzies, Inês Pires da Silva, Georgina V Long, Richard A Scolyer and James S Wilmott:
Cross‑platform comparison of immune signatures in immunotherapy‑treated patients with advanced melanoma using a rank‑based scoring approach,
Journal of Translational Medicine,
21
(2023),
257 (16 pages).
2.
Wang KYX, Menzies AM, Silva IP, Wilmott JS, Yan Y, Wongchenko M, Kefford RF, Scolyer RA, Long GV, Tarr G, Muller S, Yang YH
Kevin YX Wang, Alexander M Menzies, Ines P Silva, James S Wilmott, Yibing Yan, Matthew Wongchenko, Richard F Kefford, Richard A Scolyer, Georgina V Long, Garth Tarr, Samuel Mueller and Jean YH Yang:
bcGST – an interactive bias-correction method to identify over-represented gene-sets in boutique arrays,
Bioinformatics,
35
(2019),
no. 8,
1350–1357.
3.
Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang YH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H
Su Y Lim, Jenny H Lee, Tuba N Gide, Alexander M Menzies, Alexander Guminski, Matteo S Carlino, Edmond J Breen, Jean Y H Yang, Shila Ghazanfar, Richard F Kefford, Richard A Scolyer, Georgina V Long and Helen Rizos:
Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1–based immunotherapy,
Clinical Cancer Research,
25
(2019),
no. 5,
1557–1563.
4.
da Silva IP, Wang KYX, Wilmott JS, Holst J, Carlino MS, Park JJ, Quek C, Wongchenko M, Yan Y, Mann G, Johnson DB, Quade JLM, Rai R, Kefford RF, Rizos H, Scolyer RA, Yang YH, Long GV, Menzies AM
Inês Pires da Silva, Kevin Y.X. Wang, James S. Wilmott, Jeff Holst, Matteo S. Carlino, John J. Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham Mann, Douglas B. Johnson, Jennifer L. McQuade, Rajat Rai, Richard F. Kefford, Helen Rizos, Richard A. Scolyer, Jean Y.H. Yang, Georgina V. Long and Alexander M. Menzies:
Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma,
Clinical Cancer Research,
25
(2019),
no. 4,
1272–1279.
5.
Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang YH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H
Su Y Lim, Jenny H Lee, Tuba N Gide, Alexander M Menzies, Alexander Guminski, Matteo S Carlino, Edmond J Breen, Jean YH Yang, Shila Ghazanfar, Richard F Kefford, Richard A Scolyer, Georgina V Long, Helen Rizos:
Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-based immunotherapy,
Clinical Cancer Research,
1
(2018),
2795.2018.
6.
Madore J, Strbenac D, Vilain R, Menzies AM, Yang YH, Thompson JF, Long GV, Mann GJ, Scolyer RA, Wilmott JS
Jason Madore, Dario Strbenac, Ricardo Vilain, Alexander M Menzies, Jean Y H Yang, John F Thompson, Georgina V Long, Graham J Mann, Richard A Scolyer, and James SWilmott:
PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma,
Clinical Cancer Research,
22
(2016),
no. 15,
3915–3923.
Number of matches: 6 |